On-Demand Catalog

All sessions average between 60 and 90 minutes.

Post Grid lazy load
Compounding Drug Products Due to Supply Chain Access in Light of COVID-19
FDA’s Compounding Memorandum of Understanding with States: Questions, Concerns, and What’s Next
Continued Reliance on Foreign Drug Manufacturing and the Drug Supply Chain: Manageable Risk or Public Health Concern?
Intro to COVID-19: Drug Issues
Intro to COVID-19: Diagnostics and Laboratory Testing
Intro to COVID-19: Combating Fraudulent Products
Intro to COVID-19: Enforcement Action Guidelines, Legal Liabilities and Concerns
Intro to COVID-19: Personal Protection Equipment (PPE)
Intro to COVID-19: Ventilators and 3D Printed Devices
Intro to COVID-19: Public Readiness and Emergency Preparedness Act (PREP ACT)

Filter Results